Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P7WJ
|
||||
Former ID |
DCL000202
|
||||
Drug Name |
PSN357
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 2 | [547993] | ||
Company |
OSI Pharma
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H30ClFN6O2
|
||||
Canonical SMILES |
CN(C)CCN1CCN(CC1)C(=O)C(CC2=CC=C(C=C2)F)NC(=O)C3=CC4=CC<br />(=NC=C4N3)Cl
|
||||
InChI |
1S/C25H30ClFN6O2/c1-31(2)7-8-32-9-11-33(12-10-32)25(35)21(13-17-3-5-19(27)6-4-17)30-24(34)20-14-18-15-23(26)28-16-22(18)29-20/h3-6,14-16,21,29H,7-13H2,1-2H3,(H,30,34)/t21-/m0/s1
|
||||
InChIKey |
RDFYSUFNGGYNSK-NRFANRHFSA-N
|
||||
CAS Number |
CAS 127373-66-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Myophosphorylase | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.